Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MECA-TOX
2024-515256-21-00Phase 3Authorised
- Sponsor
- Rouen University Hospital
- Start
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of botulinum toxin type A in fecal incontinence (FI), sponsored by Rouen University Hospital. Planned start Jul 2024; status: authorised.
02
Drugs
botulinum toxin type A
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on 2024-515256-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515256-21-00.